Plasma brain natriuretic peptide assay is valuable in diagnosis of heart failure in the community, as well as in hospital

Plasma brain natriuretic peptide assay is valuable in diagnosis of heart failure in the community, as well as in hospital

Bibliográfalaš dieđut
Váldodahkkit:	Davis, R, Hobbs, R, Roalfe, A, Kenkre, J, Hare, R, Davies, M
Materiálatiipa:	Journal article
Almmustuhtton:	2000

Geahča maid

Plasma N-terminal pro-brain natriuretic peptide has similar predictive value to brain natriuretic peptide in diagnosis of heart failure in the community
Dahkki: Hobbs, R, et al.
Almmustuhtton: (2000)

Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations.
Dahkki: Hobbs, F, et al.
Almmustuhtton: (2002)

Performance characteristics of N terminal pro brain natriuretic peptide (NT-ProBNP) and BNP assays in the diagnosis of heart failure in community settings
Dahkki: Hobbs, R, et al.
Almmustuhtton: (2001)

Performance characteristics of N terminal pro brain natriuretic peptide (NT-proBNP) and BNP assays in the diagnosis of symptomatic and asymptomatic left ventricular systolic dysfunction in primary care
Dahkki: Hobbs, R, et al.
Almmustuhtton: (2001)

Mortality of patients in the UK community with left-ventricular systolic dysfunction and heart failure due to other causes
Dahkki: Davis, R, et al.
Almmustuhtton: (2003)

Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study.
Dahkki: Davis, R, et al.
Almmustuhtton: (2002)

Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population.
Dahkki: Hobbs, F, et al.
Almmustuhtton: (2002)

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study.
Dahkki: Davies, M, et al.
Almmustuhtton: (2001)

Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy study
Dahkki: Taylor, CJ, et al.
Almmustuhtton: (2022)

Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004-2018
Dahkki: Taylor, C, et al.
Almmustuhtton: (2021)

Survival in patients with prevalent all-cause heart failure and borderline left ventricular systolic dysfunction
Dahkki: Hobbs, R, et al.
Almmustuhtton: (2007)

Mortality of patients in England with left ventricular systolic dysfunction and heart failure due to other causes
Dahkki: Hobbs, R, et al.
Almmustuhtton: (2005)

Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study
Dahkki: Roalfe, A, et al.
Almmustuhtton: (2021)

Natriuretic Peptides in Chronic Heart Failure
Dahkki: Hans-Peter Brunner-La Rocca, et al.
Almmustuhtton: (2019-01-01)

Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES).
Dahkki: Hobbs, F, et al.
Almmustuhtton: (2007)

Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis
Dahkki: McLellan, J, et al.
Almmustuhtton: (2019)

Increased natriuretic peptides not associated with heart failure
Dahkki: A. M. Chaulin, et al.
Almmustuhtton: (2021-01-01)

Diagnostic accuracy and clinical impact of natriuretic peptide screening for the detection of heart failure in the community: a protocol for systematic review and meta-analysis
Dahkki: Goyder, CR, et al.
Almmustuhtton: (2019)

B-type natriuretic peptide-guided treatment for heart failure
Dahkki: McLellan, J, et al.
Almmustuhtton: (2016)

The Predictive Value of Plasma Brain Natriuretic Peptide and Galectin-3 in Elderly Patients Admitted for Heart Failure
Dahkki: Marzia Testa, et al.
Almmustuhtton: (2018-09-01)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
Dahkki: Mihai Marinescu, et al.
Almmustuhtton: (2023-04-01)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
Dahkki: Takekazu Miyoshi, et al.
Almmustuhtton: (2021-03-01)

Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations.
Dahkki: Hobbs, F, et al.
Almmustuhtton: (2004)

Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure
Dahkki: Antoni Bayes‐Genis, et al.
Almmustuhtton: (2025-02-01)

Natriuretic peptides and chronic heart failure in arterial hypertension patients
Dahkki: Yu. A. Vasuyk, et al.
Almmustuhtton: (2007-04-01)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
Dahkki: Hidetaka Hamasaki
Almmustuhtton: (2016-05-01)

Community prevalence of left ventricular dysfunction and atrial fibrillation, and impact on quality of life
Dahkki: Davis, R, et al.
Almmustuhtton: (2000)

Essential components in natriuretic peptide-guided management of heart failure: An intervention synthesis
Dahkki: Oke, J, et al.
Almmustuhtton: (2018)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
Dahkki: A. S. Galjavich, et al.
Almmustuhtton: (2016-01-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
Dahkki: A. S. Galjavich, et al.
Almmustuhtton: (2016-01-01)

Role of Brain Natriuretic Peptide assay in identifying children with pneumonia complicated by congestive cardiac failure
Dahkki: Wilson Sadoh, et al.
Almmustuhtton: (2018-12-01)

A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure.
Dahkki: Doust, J, et al.
Almmustuhtton: (2004)

Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes
Dahkki: Filipe M. Cunha, et al.
Almmustuhtton: (2017-01-01)

B-type natriuretic peptide for diagnosis and treatment of congestive heart failure
Dahkki: GM Kuster, et al.
Almmustuhtton: (2002-11-01)

Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure
Dahkki: Roberto Licordari, et al.
Almmustuhtton: (2024-03-01)

Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure
Dahkki: Shihui Fu, et al.
Almmustuhtton: (2018-01-01)

Natriuretic peptides and Galectin-3 in senile heart failure patients with preserved ejection fraction.
Dahkki: Malinova L.I., et al.
Almmustuhtton: (2015-03-01)

Value of mid-regional pro-atrial natriuretic peptide and brain natriuretic peptide for detection of acute heart failure in patients with dyspnea: diagnostic accuracy study
Dahkki: Kambiz Masoumi, et al.
Almmustuhtton: (2023-08-01)

The efficacy of different therapy protocols for heart failure in patients with heart failure and increased natriuretic peptide level
Dahkki: Kovačević Radmila, et al.
Almmustuhtton: (2009-01-01)

Brain natriuretic peptide as a diagnostic marker for heart failure in hyperthyroid patients with ischemic heart disease
Dahkki: Hazem M El-Ashmawy, et al.
Almmustuhtton: (2018-01-01)